RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGEN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Agenus Inc. stock after gaining 4.24%
(Updated on Mar 28, 2024)

Sell candidate since Mar 08, 2024 Loss -13.45% PDF

The Agenus Inc. stock price gained 4.24% on the last trading day (Thursday, 28th Mar 2024), rising from $0.556 to $0.580. During the last trading day the stock fluctuated 5.34% from a day low at $0.551 to a day high of $0.580. The price has been going up and down for this period, and there has been a -3.28% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $2.99 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.67% during the next 3 months and, with a 90% probability hold a price between $0.404 and $0.756 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGEN Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, March 18, 2024, and so far it has risen 9.50%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Agenus Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.659. On a fall, the stock will find some support from the short-term average at $0.556. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Agenus Inc. stock

Agenus Inc. finds support from accumulated volume at $0.563 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0294 between high and low, or 5.34%. For the last week, the stock has had daily average volatility of 6.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AGEN) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Agenus Inc. to open at $0.570, and during the day (based on 14 day Average True Range), to move between $0.522 and $0.638, which gives a possible trading interval of +/-$0.0583 (+/-10.05%) up or down from last closing price. If Agenus Inc. takes out the full calculated possible swing range there will be an estimated 20.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.563 (3.00%) than the resistance at $0.654 (12.72%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Agenus Inc. stock A Buy?

Agenus Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.130 Sell Candidate Unchanged

Predicted Opening Price for Agenus Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.570 ( 1.69%) $0.580

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGEN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.600 3.38 %
R2 0.588 1.44 %
R1 0.581 0.247 %
Current price: 0.580
Support S1 0.559 -3.63 %
S2 0.552 -4.82 %
S3 0.541 -6.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.682 17.60 %
R2 0.668 15.24 %
R1 0.654 12.72 %
Current price 0.580
Support S1 0.563 -3.00%
S2 0.540 -6.90%
S3 0.530 -8.67%

FAQ

What is the symbol for Agenus Inc. Stock and on which exchange is it traded?
The symbol for Agenus Inc. is AGEN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agenus Inc. Stock?
Agenus Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Agenus Inc. Stock?
Agenus Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agenus Inc. Stock.

What's the current price of Agenus Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Agenus Inc. (AGEN) share was $0.580.

What is the 52-week high and low for Agenus Inc. Stock?
The 52-week high for Agenus Inc. Stock is $2.13 and the 52-week low is $0.485.

What is the market capitalization of Agenus Inc. Stock?
As of the 2024-03-28, the market capitalization of Agenus Inc. is 242.974M.

When is the next earnings date for Agenus Inc.?
The upcoming earnings date for Agenus Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Agenus Inc.

Agenus. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The... AGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT